Page last updated: 2024-09-03

way 100135 and mecamylamine

way 100135 has been researched along with mecamylamine in 1 studies

Compound Research Comparison

Studies
(way 100135)
Trials
(way 100135)
Recent Studies (post-2010)
(way 100135)
Studies
(mecamylamine)
Trials
(mecamylamine)
Recent Studies (post-2010) (mecamylamine)
1430341,99768376

Protein Interaction Comparison

ProteinTaxonomyway 100135 (IC50)mecamylamine (IC50)
Neuronal acetylcholine receptor subunit beta-2Homo sapiens (human)0.44
Neuronal acetylcholine receptor subunit beta-4Homo sapiens (human)2.0833
Neuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)1.6133
Neuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)1.8
Neuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)0.6
Neuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)3.1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rezayof, A; Tirgar, F; Zarrindast, MR1

Other Studies

1 other study(ies) available for way 100135 and mecamylamine

ArticleYear
Central amygdala nicotinic and 5-HT1A receptors mediate the reversal effect of nicotine and MDMA on morphine-induced amnesia.
    Neuroscience, 2014, Sep-26, Volume: 277

    Topics: Amnesia; Animals; Central Amygdaloid Nucleus; Dose-Response Relationship, Drug; Male; Mecamylamine; Morphine; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Piperazines; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptors, Nicotinic; Serotonin 5-HT1 Receptor Antagonists; Serotonin Agents

2014